Home  >> Transactions>> Abbott has sold certain pharmaceutical assets to Inventiva

Abbott has sold certain pharmaceutical assets to Inventiva

Abbott Laboratories (NYSE: ABT) has sold the assets of Fournier R&D laboratories, located in Daix, France, to Inventiva, a company created as part of a management buyout. The assets include 12 000 m² of laboratories and equipment and a 230,000 molecule library, and will address four therapeutic targets: Parkinson’s disease, oncology, autoimmune diseases and fibrosis. In addition Abbott has signed a five-year partnership with Inventiva that will finance a large part of the operating costs. EC Mergers & Acquisitions acted as exclusive advisor to Abbott on this transaction.

Others

Leatherman has agreed to sell Ledlenser to Afinum      Learn More >>
4D Technology has agreed to be sold to Nanometrics      Learn More >>
MakeLeaps, Inc. has agreed to be sold to Ricoh Company, Ltd.      Learn More >>
Halma has acquired LAN Control Systems      Learn More >>
Xylem has sold Sensus Precision Die Casting (Yangzhou) to SORL Auto Parts      Learn More >>
Randstad has sold Locum Medical Group to Health Carousel      Learn More >>
EMX Industries has been sold to Watervale      Learn More >>
Steel Partners has acquired PST Group      Learn More >>
Galileo TP has been sold to Burke Porter Group      Learn More >>
Entegris Has Acquired Flex Concepts, Inc.      Learn More >>
Hänsel Group has sold a majority stake to Possehl      Learn More >>
Entegris has acquired SAES Pure Gas Business from SAES Group      Learn More >>